- €1.02bn
- €1.70bn
- €121.53m
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 133 | 110 | 118 | 126 | 122 |
Cost of Revenue | |||||
Gross Profit | 73.6 | 75.2 | 86 | 101 | 117 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 117 | 102 | 108 | 120 | 116 |
Operating Profit | 16.1 | 8.17 | 9.27 | 6.17 | 5.74 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.83 | -2.71 | 3.03 | 23.9 | -8.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.111 | 0.903 | 24.7 | 14.1 | -8.18 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.766 | 1.62 | 25.1 | 14.9 | -9.55 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.765 | 1.62 | 25.1 | 14.9 | -9.55 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.009 | 0.022 | 0.332 | 0.195 | -0.125 |
Dividends per Share |